ALDH18A1
Delta-1-pyrroline-5-carboxylate synthase
Also known as: GSAS, P5CS, P5CS_HUMAN, PYCS, SPG9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P54886
- Gene
- ALDH18A1
- Ensembl
- ENSG00000059573
- Chromosome
- 10
- Canonical length
- 795 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is a member of the aldehyde dehydrogenase family and encodes a bifunctional ATP- and NADPH-dependent mitochondrial enzyme with both gamma-glutamyl kinase and gamma-glutamyl phosphate reductase activities. The encoded protein catalyzes the reduction of glutamate to delta1-pyrroline-5-carboxylate, a critical step in the de novo biosynthesis of proline, ornithine and arginine. Mutations in this gene lead to hyperammonemia, hypoornithinemia, hypocitrullinemia, hypoargininemia and hypoprolinemia and may be associated with neurodegeneration, cataracts and connective tissue diseases. Alternatively spliced transcript variants, encoding different isoforms, have been described for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
795 residues, UniProt reviewed canonical sequence.
>P54886|ALDH18A1
1 MLSQVYRCGF QPFNQHLLPW VKCTTVFRSH CIQPSVIRHV RSWSNIPFIT VPLSRTHGKS
61 FAHRSELKHA KRIVVKLGSA VVTRGDECGL ALGRLASIVE QVSVLQNQGR EMMLVTSGAV
121 AFGKQRLRHE ILLSQSVRQA LHSGQNQLKE MAIPVLEARA CAAAGQSGLM ALYEAMFTQY
181 SICAAQILVT NLDFHDEQKR RNLNGTLHEL LRMNIVPIVN TNDAVVPPAE PNSDLQGVNV
241 ISVKDNDSLA ARLAVEMKTD LLIVLSDVEG LFDSPPGSDD AKLIDIFYPG DQQSVTFGTK
301 SRVGMGGMEA KVKAALWALQ GGTSVVIANG THPKVSGHVI TDIVEGKKVG TFFSEVKPAG
361 PTVEQQGEMA RSGGRMLATL EPEQRAEIIH HLADLLTDQR DEILLANKKD LEEAEGRLAA
421 PLLKRLSLST SKLNSLAIGL RQIAASSQDS VGRVLRRTRI AKNLELEQVT VPIGVLLVIF
481 ESRPDCLPQV AALAIASGNG LLLKGGKEAA HSNRILHLLT QEALSIHGVK EAVQLVNTRE
541 EVEDLCRLDK MIDLIIPRGS SQLVRDIQKA AKGIPVMGHS EGICHMYVDS EASVDKVTRL
601 VRDSKCEYPA ACNALETLLI HRDLLRTPLF DQIIDMLRVE QVKIHAGPKF ASYLTFSPSE
661 VKSLRTEYGD LELCIEVVDN VQDAIDHIHK YGSSHTDVIV TEDENTAEFF LQHVDSACVF
721 WNASTRFSDG YRFGLGAEVG ISTSRIHARG PVGLEGLLTT KWLLRGKDHV VSDFSEHGSL
781 KYLHENLPIP QRNTNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALDH18A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 113 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 113 nTPM
- duodenum: 84 nTPM
- small intestine: 69 nTPM
- pancreas: 58 nTPM
- colon: 49 nTPM
- rectum: 46 nTPM
Single-cell type
- salivary acinar cells: 154 nCPM
- enterocytes: 100 nCPM
- pancreatic acinar cells: 94 nCPM
- colonocytes: 91 nCPM
- lacrimal acinar cells: 89 nCPM
- lactotrophs: 86 nCPM
Immune cell
- MAIT T-cell: 29 nTPM
- memory CD8 T-cell: 28 nTPM
- gdT-cell: 27 nTPM
- NK-cell: 26 nTPM
- T-reg: 26 nTPM
- memory CD4 T-cell: 25 nTPM
Brain region
- choroid plexus: 33 nTPM
- midbrain: 20 nTPM
- thalamus: 19 nTPM
- hypothalamus: 18 nTPM
- medulla oblongata: 17 nTPM
- pons: 17 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ALDH18A1.
Disease | AllUniProt
Conditions ALDH18A1 is implicated in, by any mechanism.
- Cutis laxa, autosomal recessive, 3A (ARCL3A) MIM:219150
- Cutis laxa, autosomal dominant, 3 (ADCL3) MIM:616603
- Spastic paraplegia 9A, autosomal dominant (SPG9A) MIM:601162
- Spastic paraplegia 9B, autosomal recessive (SPG9B) MIM:616586
Disease | GeneticClinVar
61 pathogenic / likely-pathogenic of 891 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cutis laxa, autosomal dominant 3
- Autosomal dominant spastic paraplegia type 9
- de Barsy syndrome
- ALDH18A1-related de Barsy syndrome
- Autosomal recessive complex spastic paraplegia type 9B
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.97
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- citrulline biosynthetic process
- glutamate metabolic process
- L-proline biosynthetic process
- response to temperature stimulus
- ornithine biosynthetic process
Molecular functions
- ATP binding
- identical protein binding
- RNA binding
- glutamate 5-kinase activity
- glutamate-5-semialdehyde dehydrogenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aspartate/glutamate/uridylate kinase
- Aldehyde dehydrogenase domain
- Aldehyde/histidinol dehydrogenase
- Aldehyde dehydrogenase, N-terminal
- Aldehyde dehydrogenase, C-terminal
- Acetylglutamate kinase-like superfamily
- Aldehyde dehydrogenase family
- Amino acid kinase family
- GPR domain
- Glutamate/acetylglutamate kinase
- Glutamate 5-kinase/delta-1-pyrroline-5-carboxylate synthase
- Delta l-pyrroline-5-carboxylate synthetase
- Glutamate 5-kinase, conserved site
- Gamma-glutamyl phosphate reductase GPR, conserved site
- Bifunctional delta 1-pyrroline-5-carboxylate synthetase, glutamate-5-kinase domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALDH18A1 as an antibody target. Whether an autoantibody or antibody against ALDH18A1 could matter depends on whether native ALDH18A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALDH18A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ALDH18A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...